Dark Forest Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12,058
Closed -$944K – 939
2026
Q2
$944K Buy
+12,058
New +$822K 0.06% 518
2025
Q4
– Sell
-38,217
Closed -$2.8M – 1128
2025
Q3
$2.8M Buy
+38,217
New +$2.54M 0.11% 325
2023
Q4
– Sell
-6,167
Closed -$236K – 740
2023
Q3
$236K Buy
+6,167
New +$253K 0.02% 973
2022
Q1
– Sell
-9
Closed – – 1482
2021
Q4
$0 Buy
+9
New +$336 ﹤0.01% 1574

Other funds holding HALO

Dark Forest Capital Management's HALO Position: Q3 2026 in Review

Dark Forest Capital Management sold out of Halozyme (HALO) in Q3 2026, closing a stake of 12,058 shares — an estimated $944K sold.

Dark Forest Capital Management first reported a position in HALO in Q4 2021 and held it in 4 quarters. The position peaked at $2.8M in Q3 2025. 774 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Dark Forest Capital Management reported no remaining Halozyme position as of Q3 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 12,058 Halozyme shares in Q3 2026, an estimated $944K.
  • Dark Forest Capital Management first reported a position in Halozyme in Q4 2021 and held it in 4 quarters.
  • Dark Forest Capital Management's Halozyme position peaked at $2.8M in Q3 2025.
  • 774 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Dark Forest Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.